A CAPA (corrective and preventative action) program is an important indicator of a company's overall compliance efforts. It is considered a "bellwether" by the FDA. An effective CAPA program follows a closed-loop process to identify, correct, and eliminate quality issues and potential problems. It analyzes multiple sources of quality data. Failing to properly establish and maintain CAPA procedures is a common violation cited by the FDA. Ensuring a strong CAPA program that satisfies regulations like ISO 13485 and 21 CFR Part 820 can help reduce compliance risks during FDA inspections.
The document discusses elements of an effective Corrective and Preventive Action (CAPA) process. It outlines key aspects such as having a documented procedure, risk assessment, investigation techniques, defined action plans, effectiveness checks, and management review. The goals of a CAPA process are to determine the root cause of problems, implement corrective actions to address the cause, and verify that the actions were effective in preventing recurrence. An effective CAPA system relies on analyzing various quality data sources, taking actions to continuously improve products and processes, and demonstrating the ability to meet business and compliance needs over time.
This document discusses corrective and preventive action (CAPA) basics, including:
- The purpose of CAPA is to identify and address quality problems and prevent recurrence.
- Regulations require manufacturers to establish CAPA procedures, collect and analyze data, investigate issues, identify and validate corrective/preventive actions, and document activities.
- The level of CAPA should be appropriate to the risk level of the problem. Relevant information must be communicated and submitted for management review.
This document discusses corrective and preventive action (CAPA) systems and how they are used to mitigate risk. It provides three key points:
1) CAPA systems use non-conformances, deviations, and potential problems to investigate quality issues, identify corrective and preventive actions, and track the implementation of these actions.
2) CAPA aims to define the risk level associated with quality events and ensure appropriate actions are taken based on risk level, from further investigation and corrective actions for high risks to no action for low risks.
3) Effective CAPA systems incorporate change control to evaluate and document any changes made as a result of corrective actions to avoid introducing new risks.
Sop 820 capa procedure corrective preventive action med devConnie Dello Buono
This document outlines the corrective and preventive action (CAPA) procedure for addressing non-conformances and quality problems. It defines when a CAPA should be initiated, such as for systemic or repetitive issues. It describes assigning a CAPA owner to investigate the root cause and identify corrective actions. Effectiveness of these actions must be verified through follow-up audits. Preventive actions may also be initiated through trend analysis to address potential problems. All CAPAs require management review and sign-off for implementation and closure within 4 months. The CAPA coordinator communicates results and actions to management.
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
This document provides an overview of corrective and preventive action (CAPA) requirements for medical device manufacturers. It discusses the purpose and context of the CAPA subsystem, when FDA reviews CAPAs, definitions, the CAPA process, procedures, data analysis, investigations, identifying required actions, and verifying the effectiveness of actions without adversely affecting the device. The key points are that CAPA is important for ensuring problems are detected and resolved, linked to other quality system requirements, and involves analyzing data, investigating causes, identifying appropriate corrective or preventive actions, and validating their effectiveness.
This document summarizes the features and benefits of the SBS Q-Med Database software for managing quality systems in medical device and FDA-regulated industries. The software allows users to track nonconformances, corrective and preventive actions, audits, meetings, and customer satisfaction surveys. It provides templates for documentation, electronic signatures, and reporting functionality to analyze data. The software is intended to help users comply with quality standards like ISO 13485, 21 CFR 820 and improve processes through effective management of quality records and metrics.
The document discusses elements of an effective Corrective and Preventive Action (CAPA) process. It outlines key aspects such as having a documented procedure, risk assessment, investigation techniques, defined action plans, effectiveness checks, and management review. The goals of a CAPA process are to determine the root cause of problems, implement corrective actions to address the cause, and verify that the actions were effective in preventing recurrence. An effective CAPA system relies on analyzing various quality data sources, taking actions to continuously improve products and processes, and demonstrating the ability to meet business and compliance needs over time.
This document discusses corrective and preventive action (CAPA) basics, including:
- The purpose of CAPA is to identify and address quality problems and prevent recurrence.
- Regulations require manufacturers to establish CAPA procedures, collect and analyze data, investigate issues, identify and validate corrective/preventive actions, and document activities.
- The level of CAPA should be appropriate to the risk level of the problem. Relevant information must be communicated and submitted for management review.
This document discusses corrective and preventive action (CAPA) systems and how they are used to mitigate risk. It provides three key points:
1) CAPA systems use non-conformances, deviations, and potential problems to investigate quality issues, identify corrective and preventive actions, and track the implementation of these actions.
2) CAPA aims to define the risk level associated with quality events and ensure appropriate actions are taken based on risk level, from further investigation and corrective actions for high risks to no action for low risks.
3) Effective CAPA systems incorporate change control to evaluate and document any changes made as a result of corrective actions to avoid introducing new risks.
Sop 820 capa procedure corrective preventive action med devConnie Dello Buono
This document outlines the corrective and preventive action (CAPA) procedure for addressing non-conformances and quality problems. It defines when a CAPA should be initiated, such as for systemic or repetitive issues. It describes assigning a CAPA owner to investigate the root cause and identify corrective actions. Effectiveness of these actions must be verified through follow-up audits. Preventive actions may also be initiated through trend analysis to address potential problems. All CAPAs require management review and sign-off for implementation and closure within 4 months. The CAPA coordinator communicates results and actions to management.
A structured approach to the investigation process should be used with the objective of determining the root cause.
The level of effort, formality, and documentation of the investigation should be commensurate with the level of risk, in line with ICH Q9.
This document provides an overview of corrective and preventive action (CAPA) requirements for medical device manufacturers. It discusses the purpose and context of the CAPA subsystem, when FDA reviews CAPAs, definitions, the CAPA process, procedures, data analysis, investigations, identifying required actions, and verifying the effectiveness of actions without adversely affecting the device. The key points are that CAPA is important for ensuring problems are detected and resolved, linked to other quality system requirements, and involves analyzing data, investigating causes, identifying appropriate corrective or preventive actions, and validating their effectiveness.
This document summarizes the features and benefits of the SBS Q-Med Database software for managing quality systems in medical device and FDA-regulated industries. The software allows users to track nonconformances, corrective and preventive actions, audits, meetings, and customer satisfaction surveys. It provides templates for documentation, electronic signatures, and reporting functionality to analyze data. The software is intended to help users comply with quality standards like ISO 13485, 21 CFR 820 and improve processes through effective management of quality records and metrics.
CAPA Management | What is CAPA? | Corrective And Preventive ActionAnil Chaudhari
CAPA (Corrective and Preventive Action) is a quality management system used in the pharmaceutical and medical device industries to continuously improve processes, procedures, and the organization. CAPA involves corrective actions to address existing issues and preventive actions to prevent potential problems. The CAPA process follows the PDCA (Plan-Do-Check-Act) cycle. PDCA involves planning improvements, implementing them, checking results, and acting to correct or improve further. The goal of CAPA and PDCA is continual improvement through systematically addressing problems, identifying root causes, and verifying that issues have been resolved.
CAPA - Corrective and Preventive Action Management TrainingTonex
"CAPA Management training covers the rationale, concepts, tools, techniques, and practices of RCA and Corrective and Preventive Action (CAPA) management in FDA field".
TONEX RCA and CAPA Management Training Format
The course is fun and dynamic
The training is a blend of hypothesis and practice
The hypothetical area is conveyed as intuitive introduction
The reasonable area incorporates practicing with genuine precedents, singular/bunch exercises, and hands-on workshops
Learn About:
CAPA application and implementation
CAPA management
FDA’s requirements for CAPA systems
Importance of CAPA systems
CAPA system main components
The definition and differences of the terms corrections, corrective actions, and preventive actions
CAPA data sources
Methods of data analysis
CAPA data flow charts
CAPA tracking tools
Medical device reporting and tracking
FDA guidance for failure investigations and root cause analyses
FDA’s trending principals / ECI
Non-conformances or deviations
RCA tools and methods
Brainstorming methods
Problem solving tools
Process mapping / Regulatory resources
Corrective action plan development steps
Defining the problem statement properly
Isolating and containing the problems
Identifying the root cause
Developing an effective corrective action
Executing and validating the corrective action
Preventing recurrence
Preventive Action process
Communication
Course Outline
Overview of CAPA
RCA Definition
Non-Conformances or Deviations
Nonconformance Classification
Problem Solving Process
Creative Thinking Approaches
FMEA Application in Clinical Devices
Analysis and Prioritization Techniques
Digging Down for the Root Causes
Gathering Valuable Data for RCA and CAPA
Analyzing Data
Accidents Analysis and Role of Human Error
Role of Management Behaviors in the Success of RCA/CAPA
Implementing Corrective and Preventive Action Plans (CAPA)
Elements of Effective CAPA
Trending Requirements and CAPA
CAPA Regulatory Requirements
Call us today at +1-972-665-9786. Learn more about this course audience, objectives, outlines, seminars, pricing , any other information. Visit our website link below.
CAPA (Corrective and Preventive Action) Management Training
https://www.tonex.com/training-courses/capa-management-training/
Managing non conformities through , how to reduce element that lowers qualitychakalisa chicho
The document discusses managing non-conformities through effective corrective and preventive action. It defines problems, non-conformities, sources of quality problems, and the difference between symptoms and causes. It then defines corrective action as action taken after a non-conformity to address the root cause, while preventive action is proactive in identifying potential issues. Effective corrective and preventive action requires understanding systems, variation, theory, tools like the PDSA cycle and 5 Whys, and applying a problem-solving process.
Corrective Action – The Heart of Continuous QualityIBS America
In the latest managing continuous improvement webinar from IBS America, Inc., attendees learned how to use Corrective Actions to improve quality, enhance interdepartmental communications, and increase customer satisfaction.
In this webinar, we covered:
-Why Corrective Actions are important
-How to get the entire enterprise involved
-What tools you can use to manage the process
Visit the IBS Blog for more information and to register for our next webinar:
http://info.ibs-us.com
CAPA: Using Risk-Based Decision-Making Toward ClosureApril Bright
Implementing a risk‐based CAPA process within a QMS is a necessity in the improvement of controls aligned with product and process non-conformances, adverse events, audit findings, complaints, etc. Making decisions concerning scope and extent about these “defectives” is a modern and cost-saving approach to improvement and compliance. Every non-conformity does not force you to open a corrective action. While almost every problematic issue needs at least a correction, the biggest payback is to use corrective actions on systemically-driven problems that are repetitive and recurring.
Applying the methods of determining risk to the device’s complete life cycle will give your company a complete look at all of the device’s risks—including those relative to processes. Manufacturers should be able to justify that they have reduced the risks as far as possible as part of their risk management plan and ongoing corrective and preventive actions.
Risk Assessment for CAPA Determoination (decision)Tarek Elneil
This document provides guidance on applying risk management principles to determine corrective and preventive action (CAPA) decisions. It defines factors for assessing risk, including severity, frequency, and detectability. Risk scores are calculated based on these factors for both product risks and compliance risks. The document provides a risk priority number matrix and guidance on CAPA decisions based on the risk assessment.
This document provides an overview of corrective and preventive actions (CAPA) as part of a quality management system. It defines CAPA and explains that it aims to eliminate causes of nonconformities and prevent their recurrence. The document outlines the CAPA process, which involves nonconformance identification, root cause analysis, corrective action planning, implementation, and follow-up to verify effectiveness. It emphasizes that CAPA is important for continuous quality improvement.
Effective CAPA Implementation in a Management System - Praneet SurtiPraneet Surti
The document discusses the Corrective Action and Preventive Action (CAPA) process. It defines CAPA as a structured way to investigate non-conformities, determine appropriate corrections and actions, and measure their effectiveness. It outlines the key steps in the CAPA process including defining the problem, investigating the root cause, determining corrective and preventive actions, implementing solutions, and measuring effectiveness. The document emphasizes that the goal of CAPA is to eliminate causes of issues in order to prevent recurrence and notes that a mature CAPA system can help continuously improve products, services, and compliance.
CAPA (Corrective and Preventive Action) Management : Tonex TrainingBryan Len
CAPA Management training covers the rationale, concepts, tools, techniques, and practices of RCA and Corrective and Preventive Action (CAPA) management in FDA field. Root Cause Analysis (RCA) and Corrective and Preventive Action (CAPA) Management training course teaches you to develop an effective RCA investigation, and develop a corrective and preventive action plan suitable for the identified problems.
Learn About:
CAPA application and implementation
CAPA management
FDA’s requirements for CAPA systems
Importance of CAPA systems
CAPA system main components
CAPA data sources, Methods of data analysis
CAPA data flow charts, CAPA tracking tools
Medical device reporting and tracking
FDA guidance for failure investigations and root cause analyses
FDA’s trending principals, ECI
Non-conformances or deviations
RCA tools and methods, Brainstorming methods
More...
TONEX RCA and CAPA Management Training Format:
The course is fun and dynamic
The training is a combination of theory and practice
The theoretical section is delivered in the form of interactive presentation
The practical section includes exercising with real-world examples, individual/group activities, and hands-on workshops
Audience:
CAPA Management is a 4-day course designed for:
CRAs
Project Managers/CRA Managers
Principal Investigators
Site Research Directors/Managers
Clinical Research Coordinators
QA/QC staff
GMP personnel
All individuals who are involved in investigations in a pharmaceutical, clinical manufacturing, biologics and medical device environment.
Training Objectives:
CAPA Management training course, the attendees are able to:
Describe what RCA and CAPA are
Identify the non-compliance, Define the investigator
Discuss performance management concepts
Know the purpose of Corrective and Preventive Action
Improve their RCA and CAPA executive skills for effective site risk management
Understand the requirements in 21 CFR 820 Quality
System Regulation
Foster prevention actions
More...
Course Outline:
Overview of CAPA
RCA Definition
Non-Conformances or Deviations
Nonconformance Classification
Problem Solving Process
Creative Thinking Approaches
FMEA Application in Clinical Devices
Analysis and Prioritization Techniques
Digging Down for the Root Causes
Gathering Valuable Data for RCA and CAPA
Analyzing Data
Accidents Analysis and Role of Human Error
Role of Management Behaviors in the Success of RCA/CAPA
Implementing Corrective and Preventive Action Plans (CAPA)
Elements of Effective CAPA
Trending Requirements and CAPA
CAPA Regulatory Requirements
TONEX RCA and CAPA Hands-On Workshop Sample
Learn more. Request more information. Visit Tonex training website link below. Ask for anything related to CAPA (Corrective and Preventive Action) Management Training.
CAPA (Corrective and Preventive Action) Management Training
https://www.tonex.com/training-courses/capa-management-training/
The document outlines a 5-step process for successful Corrective and Preventive Action (CAPA): 1) Identify issues and nonconformances, 2) Implement corrective or preventive actions, 3) Verify that the actions addressed the issues, 4) Review the process for additional improvements, 5) Analyze data for trends. CAPA is important for compliance with Good Manufacturing Practices and focuses on both correcting past issues and preventing future discrepancies.
Corretive & Preventive Action (CAPA) 101jscover
This document provides an overview of corrective action (CA) and preventive action (PA) as part of a quality assurance workshop. It defines CA and PA, discusses when each is used, and provides examples. The workshop includes group activities where participants analyze case studies to identify the root cause and propose a CA or PA plan. The document emphasizes that both CA and PA are critical to continuous improvement and ensuring quality in tissue banking organizations.
Capa quality system – more than just corrective actionQuality Management
http://qualitymanagementsystem.com/what-is-iso/capa-quality-system-more-than-just-corrective-action/
A CAPA Quality System (CAPA is an acronym for ‘Corrective and Preventive Action’, or ‘Corrective Action, Preventive Action’) is absolutely essential in some format for a complete quality management program. In fact, in at least one quality management system, Good Manufacturing Practices (GMP), it is a requirement and a fundamental tenet of the program. GMP is the quality management system that must be used by pharmaceutical and medical equipment manufacturers to comply with FDA guidelines.
This document discusses elements of an effective deviation management program. It begins by defining deviation as any departure from standard operating procedures or quality requirements. An effective deviation management program includes risk management, root cause analysis, corrective and preventive action procedures, and data collection to assess effectiveness. Root cause analysis identifies underlying systemic causes of problems rather than just direct causes. Establishing the right corrective and preventive actions is important to eliminate or mitigate future risks of deviations. Managing deviations effectively supports quality, continuous improvement, and achieving organizational objectives.
A risk-based CAPA process is a common goal of medical device manufacturers, but until recently “risk-based” was not clearly defined.
The biggest fundamental change in both ISO 9001:2015 and ISO 13485:2016 is an emphasis on risk-based process management.
The CAPA process is the heart of your quality system and one of the most important processes. Therefore, this presentation gives you a whole new set of tools for managing your CAPA process using risk-based approach
A risk-based CAPA process is more than prioritization.
This presentation includes:
-An outline of the CAPA process and proposed risk management activities
-Various risk control options that can be integrated with corrective actions
-How to reconcile conflicts between the definitions for risk in ISO 9001:2015 and ISO 13485:2016
-And more...
Watch the presentation here: https://www.greenlight.guru/webinar/risk-based-capa-process
1) Dr. Obaid Ali discussed the appropriate use of Quality Risk Management (QRM) to facilitate regulatory compliance without removing industry's obligation to adhere to requirements.
2) The document defines key terms related to quality risk management including harm, hazard, hazardous situation, risk, residual risk, severity, and detectability based on ICH Q9 and ISO 14971.
3) Regulatory observations from authorities in France, South Africa, and the US FDA are presented that highlight failures to adequately perform risk assessment and management.
The document discusses emerging challenges related to ICH Q8 and Q10 implementation, including increased risk and non-compliance due to process variability. It also discusses how quality inspectors and assessors can evaluate product control strategy, quality by design, manufacturing processes, and change management systems. The rest of the document focuses on knowledge management, data integrity, and quality metrics as indicators of operational reliability and quality culture. Key quality metrics discussed include lot acceptance rate, product quality complaint rate, right first time rate, invalidated OOS rate, APR/PQR on time rate, CAPA rate, and ability to initiate voluntary CAPA.
The document discusses Corrective and Preventative Action (CAPA) systems used to eliminate existing quality issues and prevent future problems. It defines key terms like nonconformity and describes the general CAPA process. Specific root cause analysis tools are also outlined, including 5 Whys, fishbone diagrams, Pareto charts, fault tree analysis, and failure mode and effects analysis. Each tool's purpose, methodology, advantages, and limitations are summarized. Finally, preventative action and risk management processes are covered.
This document discusses anomalies, complaints, non-compliances, and corrective and preventative actions as required by ISO 17025. It outlines the process laboratories must follow to investigate problems, determine the root cause, consider and select options to immediately correct the problem and prevent reoccurrence, and then review the effectiveness of the actions. This includes using tools like fishbone diagrams and SMART criteria to aid the investigation and ensure corrective actions sufficiently address the root cause. Preventative actions focus on proactively improving processes rather than reacting to identified problems. Effective corrective and preventative actions can help laboratories continually improve and reduce future issues.
This document discusses the application of ICH Q8 and Q10 principles to pharmaceutical product development and manufacturing. It begins with an example of a dissolution failure incident to highlight the importance of understanding products and processes. It then outlines tools and approaches like knowledge management and quality risk management that can be used from development through commercial manufacturing following ICH Q8 and Q10 guidelines. Finally, it provides a case study example of how these principles were applied to the development of the drug Saxagliptin.
Performance metrics are an essential element of the management review process.
Quality metrics may include elements such as customer satisfaction, supplier performance, manufacturing defects, complaints, cycle times and many other internal or external processes.
This presentation provides a framework for establishing right quality indicators for evaluating the performance of the quality system.
The document discusses implementing an effective quality management system (QMS) and overcoming challenges with current systems. It outlines regulations around corrective and preventive action (CAPA) from ISO, FDA and EU directives. Traditional QMS have challenges with problem identification, investigation, planning, implementation, and review/approval of CAPAs. The solution proposed is a holistic approach to quality management using a quality management software solution to address these challenges and obtain full regulatory compliance through continuous improvement.
The document discusses implementing a holistic quality management system (QMS) by redefining corrective and preventive action (CAPA). It outlines challenges with traditional QMS approaches and regulations from ISO, FDA, and the European Commission regarding CAPA. The document recommends treating any opportunity to improve quality as a CAPA, and that CAPAs should follow a process from identifying problems to verifying the effectiveness of corrective actions.
CAPA Management | What is CAPA? | Corrective And Preventive ActionAnil Chaudhari
CAPA (Corrective and Preventive Action) is a quality management system used in the pharmaceutical and medical device industries to continuously improve processes, procedures, and the organization. CAPA involves corrective actions to address existing issues and preventive actions to prevent potential problems. The CAPA process follows the PDCA (Plan-Do-Check-Act) cycle. PDCA involves planning improvements, implementing them, checking results, and acting to correct or improve further. The goal of CAPA and PDCA is continual improvement through systematically addressing problems, identifying root causes, and verifying that issues have been resolved.
CAPA - Corrective and Preventive Action Management TrainingTonex
"CAPA Management training covers the rationale, concepts, tools, techniques, and practices of RCA and Corrective and Preventive Action (CAPA) management in FDA field".
TONEX RCA and CAPA Management Training Format
The course is fun and dynamic
The training is a blend of hypothesis and practice
The hypothetical area is conveyed as intuitive introduction
The reasonable area incorporates practicing with genuine precedents, singular/bunch exercises, and hands-on workshops
Learn About:
CAPA application and implementation
CAPA management
FDA’s requirements for CAPA systems
Importance of CAPA systems
CAPA system main components
The definition and differences of the terms corrections, corrective actions, and preventive actions
CAPA data sources
Methods of data analysis
CAPA data flow charts
CAPA tracking tools
Medical device reporting and tracking
FDA guidance for failure investigations and root cause analyses
FDA’s trending principals / ECI
Non-conformances or deviations
RCA tools and methods
Brainstorming methods
Problem solving tools
Process mapping / Regulatory resources
Corrective action plan development steps
Defining the problem statement properly
Isolating and containing the problems
Identifying the root cause
Developing an effective corrective action
Executing and validating the corrective action
Preventing recurrence
Preventive Action process
Communication
Course Outline
Overview of CAPA
RCA Definition
Non-Conformances or Deviations
Nonconformance Classification
Problem Solving Process
Creative Thinking Approaches
FMEA Application in Clinical Devices
Analysis and Prioritization Techniques
Digging Down for the Root Causes
Gathering Valuable Data for RCA and CAPA
Analyzing Data
Accidents Analysis and Role of Human Error
Role of Management Behaviors in the Success of RCA/CAPA
Implementing Corrective and Preventive Action Plans (CAPA)
Elements of Effective CAPA
Trending Requirements and CAPA
CAPA Regulatory Requirements
Call us today at +1-972-665-9786. Learn more about this course audience, objectives, outlines, seminars, pricing , any other information. Visit our website link below.
CAPA (Corrective and Preventive Action) Management Training
https://www.tonex.com/training-courses/capa-management-training/
Managing non conformities through , how to reduce element that lowers qualitychakalisa chicho
The document discusses managing non-conformities through effective corrective and preventive action. It defines problems, non-conformities, sources of quality problems, and the difference between symptoms and causes. It then defines corrective action as action taken after a non-conformity to address the root cause, while preventive action is proactive in identifying potential issues. Effective corrective and preventive action requires understanding systems, variation, theory, tools like the PDSA cycle and 5 Whys, and applying a problem-solving process.
Corrective Action – The Heart of Continuous QualityIBS America
In the latest managing continuous improvement webinar from IBS America, Inc., attendees learned how to use Corrective Actions to improve quality, enhance interdepartmental communications, and increase customer satisfaction.
In this webinar, we covered:
-Why Corrective Actions are important
-How to get the entire enterprise involved
-What tools you can use to manage the process
Visit the IBS Blog for more information and to register for our next webinar:
http://info.ibs-us.com
CAPA: Using Risk-Based Decision-Making Toward ClosureApril Bright
Implementing a risk‐based CAPA process within a QMS is a necessity in the improvement of controls aligned with product and process non-conformances, adverse events, audit findings, complaints, etc. Making decisions concerning scope and extent about these “defectives” is a modern and cost-saving approach to improvement and compliance. Every non-conformity does not force you to open a corrective action. While almost every problematic issue needs at least a correction, the biggest payback is to use corrective actions on systemically-driven problems that are repetitive and recurring.
Applying the methods of determining risk to the device’s complete life cycle will give your company a complete look at all of the device’s risks—including those relative to processes. Manufacturers should be able to justify that they have reduced the risks as far as possible as part of their risk management plan and ongoing corrective and preventive actions.
Risk Assessment for CAPA Determoination (decision)Tarek Elneil
This document provides guidance on applying risk management principles to determine corrective and preventive action (CAPA) decisions. It defines factors for assessing risk, including severity, frequency, and detectability. Risk scores are calculated based on these factors for both product risks and compliance risks. The document provides a risk priority number matrix and guidance on CAPA decisions based on the risk assessment.
This document provides an overview of corrective and preventive actions (CAPA) as part of a quality management system. It defines CAPA and explains that it aims to eliminate causes of nonconformities and prevent their recurrence. The document outlines the CAPA process, which involves nonconformance identification, root cause analysis, corrective action planning, implementation, and follow-up to verify effectiveness. It emphasizes that CAPA is important for continuous quality improvement.
Effective CAPA Implementation in a Management System - Praneet SurtiPraneet Surti
The document discusses the Corrective Action and Preventive Action (CAPA) process. It defines CAPA as a structured way to investigate non-conformities, determine appropriate corrections and actions, and measure their effectiveness. It outlines the key steps in the CAPA process including defining the problem, investigating the root cause, determining corrective and preventive actions, implementing solutions, and measuring effectiveness. The document emphasizes that the goal of CAPA is to eliminate causes of issues in order to prevent recurrence and notes that a mature CAPA system can help continuously improve products, services, and compliance.
CAPA (Corrective and Preventive Action) Management : Tonex TrainingBryan Len
CAPA Management training covers the rationale, concepts, tools, techniques, and practices of RCA and Corrective and Preventive Action (CAPA) management in FDA field. Root Cause Analysis (RCA) and Corrective and Preventive Action (CAPA) Management training course teaches you to develop an effective RCA investigation, and develop a corrective and preventive action plan suitable for the identified problems.
Learn About:
CAPA application and implementation
CAPA management
FDA’s requirements for CAPA systems
Importance of CAPA systems
CAPA system main components
CAPA data sources, Methods of data analysis
CAPA data flow charts, CAPA tracking tools
Medical device reporting and tracking
FDA guidance for failure investigations and root cause analyses
FDA’s trending principals, ECI
Non-conformances or deviations
RCA tools and methods, Brainstorming methods
More...
TONEX RCA and CAPA Management Training Format:
The course is fun and dynamic
The training is a combination of theory and practice
The theoretical section is delivered in the form of interactive presentation
The practical section includes exercising with real-world examples, individual/group activities, and hands-on workshops
Audience:
CAPA Management is a 4-day course designed for:
CRAs
Project Managers/CRA Managers
Principal Investigators
Site Research Directors/Managers
Clinical Research Coordinators
QA/QC staff
GMP personnel
All individuals who are involved in investigations in a pharmaceutical, clinical manufacturing, biologics and medical device environment.
Training Objectives:
CAPA Management training course, the attendees are able to:
Describe what RCA and CAPA are
Identify the non-compliance, Define the investigator
Discuss performance management concepts
Know the purpose of Corrective and Preventive Action
Improve their RCA and CAPA executive skills for effective site risk management
Understand the requirements in 21 CFR 820 Quality
System Regulation
Foster prevention actions
More...
Course Outline:
Overview of CAPA
RCA Definition
Non-Conformances or Deviations
Nonconformance Classification
Problem Solving Process
Creative Thinking Approaches
FMEA Application in Clinical Devices
Analysis and Prioritization Techniques
Digging Down for the Root Causes
Gathering Valuable Data for RCA and CAPA
Analyzing Data
Accidents Analysis and Role of Human Error
Role of Management Behaviors in the Success of RCA/CAPA
Implementing Corrective and Preventive Action Plans (CAPA)
Elements of Effective CAPA
Trending Requirements and CAPA
CAPA Regulatory Requirements
TONEX RCA and CAPA Hands-On Workshop Sample
Learn more. Request more information. Visit Tonex training website link below. Ask for anything related to CAPA (Corrective and Preventive Action) Management Training.
CAPA (Corrective and Preventive Action) Management Training
https://www.tonex.com/training-courses/capa-management-training/
The document outlines a 5-step process for successful Corrective and Preventive Action (CAPA): 1) Identify issues and nonconformances, 2) Implement corrective or preventive actions, 3) Verify that the actions addressed the issues, 4) Review the process for additional improvements, 5) Analyze data for trends. CAPA is important for compliance with Good Manufacturing Practices and focuses on both correcting past issues and preventing future discrepancies.
Corretive & Preventive Action (CAPA) 101jscover
This document provides an overview of corrective action (CA) and preventive action (PA) as part of a quality assurance workshop. It defines CA and PA, discusses when each is used, and provides examples. The workshop includes group activities where participants analyze case studies to identify the root cause and propose a CA or PA plan. The document emphasizes that both CA and PA are critical to continuous improvement and ensuring quality in tissue banking organizations.
Capa quality system – more than just corrective actionQuality Management
http://qualitymanagementsystem.com/what-is-iso/capa-quality-system-more-than-just-corrective-action/
A CAPA Quality System (CAPA is an acronym for ‘Corrective and Preventive Action’, or ‘Corrective Action, Preventive Action’) is absolutely essential in some format for a complete quality management program. In fact, in at least one quality management system, Good Manufacturing Practices (GMP), it is a requirement and a fundamental tenet of the program. GMP is the quality management system that must be used by pharmaceutical and medical equipment manufacturers to comply with FDA guidelines.
This document discusses elements of an effective deviation management program. It begins by defining deviation as any departure from standard operating procedures or quality requirements. An effective deviation management program includes risk management, root cause analysis, corrective and preventive action procedures, and data collection to assess effectiveness. Root cause analysis identifies underlying systemic causes of problems rather than just direct causes. Establishing the right corrective and preventive actions is important to eliminate or mitigate future risks of deviations. Managing deviations effectively supports quality, continuous improvement, and achieving organizational objectives.
A risk-based CAPA process is a common goal of medical device manufacturers, but until recently “risk-based” was not clearly defined.
The biggest fundamental change in both ISO 9001:2015 and ISO 13485:2016 is an emphasis on risk-based process management.
The CAPA process is the heart of your quality system and one of the most important processes. Therefore, this presentation gives you a whole new set of tools for managing your CAPA process using risk-based approach
A risk-based CAPA process is more than prioritization.
This presentation includes:
-An outline of the CAPA process and proposed risk management activities
-Various risk control options that can be integrated with corrective actions
-How to reconcile conflicts between the definitions for risk in ISO 9001:2015 and ISO 13485:2016
-And more...
Watch the presentation here: https://www.greenlight.guru/webinar/risk-based-capa-process
1) Dr. Obaid Ali discussed the appropriate use of Quality Risk Management (QRM) to facilitate regulatory compliance without removing industry's obligation to adhere to requirements.
2) The document defines key terms related to quality risk management including harm, hazard, hazardous situation, risk, residual risk, severity, and detectability based on ICH Q9 and ISO 14971.
3) Regulatory observations from authorities in France, South Africa, and the US FDA are presented that highlight failures to adequately perform risk assessment and management.
The document discusses emerging challenges related to ICH Q8 and Q10 implementation, including increased risk and non-compliance due to process variability. It also discusses how quality inspectors and assessors can evaluate product control strategy, quality by design, manufacturing processes, and change management systems. The rest of the document focuses on knowledge management, data integrity, and quality metrics as indicators of operational reliability and quality culture. Key quality metrics discussed include lot acceptance rate, product quality complaint rate, right first time rate, invalidated OOS rate, APR/PQR on time rate, CAPA rate, and ability to initiate voluntary CAPA.
The document discusses Corrective and Preventative Action (CAPA) systems used to eliminate existing quality issues and prevent future problems. It defines key terms like nonconformity and describes the general CAPA process. Specific root cause analysis tools are also outlined, including 5 Whys, fishbone diagrams, Pareto charts, fault tree analysis, and failure mode and effects analysis. Each tool's purpose, methodology, advantages, and limitations are summarized. Finally, preventative action and risk management processes are covered.
This document discusses anomalies, complaints, non-compliances, and corrective and preventative actions as required by ISO 17025. It outlines the process laboratories must follow to investigate problems, determine the root cause, consider and select options to immediately correct the problem and prevent reoccurrence, and then review the effectiveness of the actions. This includes using tools like fishbone diagrams and SMART criteria to aid the investigation and ensure corrective actions sufficiently address the root cause. Preventative actions focus on proactively improving processes rather than reacting to identified problems. Effective corrective and preventative actions can help laboratories continually improve and reduce future issues.
This document discusses the application of ICH Q8 and Q10 principles to pharmaceutical product development and manufacturing. It begins with an example of a dissolution failure incident to highlight the importance of understanding products and processes. It then outlines tools and approaches like knowledge management and quality risk management that can be used from development through commercial manufacturing following ICH Q8 and Q10 guidelines. Finally, it provides a case study example of how these principles were applied to the development of the drug Saxagliptin.
Performance metrics are an essential element of the management review process.
Quality metrics may include elements such as customer satisfaction, supplier performance, manufacturing defects, complaints, cycle times and many other internal or external processes.
This presentation provides a framework for establishing right quality indicators for evaluating the performance of the quality system.
The document discusses implementing an effective quality management system (QMS) and overcoming challenges with current systems. It outlines regulations around corrective and preventive action (CAPA) from ISO, FDA and EU directives. Traditional QMS have challenges with problem identification, investigation, planning, implementation, and review/approval of CAPAs. The solution proposed is a holistic approach to quality management using a quality management software solution to address these challenges and obtain full regulatory compliance through continuous improvement.
The document discusses implementing a holistic quality management system (QMS) by redefining corrective and preventive action (CAPA). It outlines challenges with traditional QMS approaches and regulations from ISO, FDA, and the European Commission regarding CAPA. The document recommends treating any opportunity to improve quality as a CAPA, and that CAPAs should follow a process from identifying problems to verifying the effectiveness of corrective actions.
Computerized system validation (CSV) as a requirement for good manufacturing ...Ahmed Hasham
The biopharmaceutical industries has more and more used computers to support and accelrate producing of their
products. Computer systems also are accustomed support routine offer of high quality products to boost production
process performance, scale back production prices, and improve product quality. it's vital that these systems square
measure suitable purpose from a business and restrictive perspective. Regulatory authorities treat a lack of regulatory
computer system compliance as a serious GxP deviation.
FDA Update: Inspections, Observations and Metrics - OMTEC 2017April Bright
This FDA-focused presentation offers a glimpse into trends behind three initiatives that orthopaedic device professionals need to fully understand: inspections, Case for Quality and 483 Observations. First, a high-level view of FDA inspections will discuss methodology and implementation. Second, FDA’s observations of non-compliance will be discussed, pointing out important historical trends. Finally, as the industry matures, professionals should expect changes to the breadth and depth of FDA’s focus. This is where Case for Quality and the Medical Device Metrics Initiative will be covered. FDA has placed an increased emphasis on data and metrics. Gain insight into ways to leverage data to improve, monitor and control processes that drive quality improvement.
Implementing Automated Qms For Business ExcellenceKhalizan Halid
The document discusses implementing an automated quality management system. It begins with background on diagnostic and analytical markets dealing with large sample volumes. Typical issues faced are resource-intensive documentation, limited auditing, and unreported issues. The need for automation is driven by increased regulations and resources. Challenges include financial resources, resistance to change, and user-friendliness. The document outlines the quality management process and developing quality management capability through generations. It emphasizes benefits like improved processes and compliance.
Computerized System Validation Business Intelligence SolutionsDigital-360
Executive Summary
Regulated pharmaceutical, biotech and medical device companies are challenged to develop manufacturing capabilities quickly and cost-effectively while at the same time safeguarding product quality and patient safety.
Validation has been an essential part of regulated industries for over 20 years, yet as the field has evolved, little has changed in the business, or manual, approach to validation.
PAT and QbD concepts in designing the LiMS and other Electronic systems in La...balakrishna t
This document provides an overview of BizBites, a business intelligence and technology solutions provider based in the UK and India since 2004 and 2011 respectively. It also describes tQmlab, one of BizBites' premier management systems for GxP operations and enabling regulatory submissions. tQmlab delivers improved productivity for QA/QC labs through customized workflows for quality control, stability testing, product release testing, and post-release quality testing. It also enables process analytical technology controls in pharmaceutical manufacturing and analytical processes.
Know what are the 5 most common reasons behind CAPA Management problems and how to deal with them with the help of Qualityze CAPA Management software. Request for demo today
GAMP 5 provides a framework for validating computerized systems used in regulated industries. It recommends a life cycle approach involving quality risk management throughout planning, development, validation and operation. Key activities for regulated companies include governance, identifying systems' impact, and ensuring compliance. Suppliers play an important role by providing documentation, testing systems, and supporting changes and maintenance. The level of validation should be based on a system's risk, complexity and novelty.
This presentation reviews the regulatory requirements for intended use validation of SaaS-based EDC systems from the Sponsor and CRO perspective and provides best practices for implementing the proper validation in your organization.
This document discusses corrective and preventive action (CAPA) systems. It defines key terms like nonconformance and defines CAPA's goals of eliminating causes of non-conformities. CAPA has two functions - corrective actions to address root causes of problems, and preventive actions to prevent reoccurrence. The document outlines objectives of an effective CAPA system and provides steps to implement corrective and preventive actions, including defining problems, identifying causes, designing measures, and ensuring documentation is updated. It stresses the importance of planning, communication, and documentation for successful CAPA execution.
AmpleLogic Quality Management System (QMS) is a web-based quality management software that provides an end to end solution to the organizations that enables to automate or eliminate paper-based the processes and integrating them across a single platform. This will bring exceptional transparency across all the systems and in resolving your issues down their roots.
AmpleLogic Quality Management System is a web based QMS software that helps organizations to efficiently monitor, manage and meet your quality goals. Our integrated quality management software that handles various modules such as CAPA, Change Control, Deviations, Market Complaints, Document and Training Management, OOS/OOT, Audit and Vendor Management etc. It is specifically designed for highly regulatory industries like Pharmaceutical, Life Sciences, Biotechnology and Healthcare etc.
This document provides an overview of quality assurance tools and techniques used in the pharmaceutical industry. It defines quality assurance and discusses its advantages in providing high quality drugs and preventing defects. Disadvantages include perfection being difficult and limits being set. Tools covered include total quality management, quality control systems, documentation, and validation. Six sigma methodology is also described as a quality assurance technique. The roles and approaches of six sigma are explained. In conclusion, quality assurance is presented as an important preventative activity for quality improvement through management and employee development.
Effective Medical Device Validation Introduction Web 2paulsorohan
This document provides an overview of the contents of a presentation on medical device compliance and validation. The presentation covers regulatory requirements, quality management systems, documentation, auditing, risk management, design controls, validation approaches across the product lifecycle including installation qualification, operation qualification, performance qualification and revalidation. It also discusses quality tools such as statistical process control.
Corrective actions and preventive actionsANKUSH JADHAV
This document discusses corrective and preventive actions (CAPA) in quality management. CAPA aims to eliminate causes of non-conformities or undesirable situations. It has two functions - corrective action finds root causes of problems and takes direct action, while preventive action informs an organization to prevent problems from recurring. Successful CAPA implementation requires effective planning, preparation, writing, evaluation, procedure updates, execution proof, change management and meetings. CAPA plays an important role in continuously improving products and processes in a quality management system.
EduQuest Advisory 4 Pillars Of Qsr ComplianceEduQuest, Inc.
FDA believes four core quality subsystems should be the foundation of every firm’s quality efforts. This Advisory, written by Denise Dion, a former FDA investigator and now a Vice President of EduQuest, focuses on what you need to know about Management Controls; Design Controls;Corrective and Preventive Actions (CAPA Systems); and Production and Process Controls (P&PC)-- plus the very important inter-linkages of each.
QMS Effectiveness: Tracking and Trending Quality Data - OMTEC 2017April Bright
What measurements are useful, and which metrics’ baseline makes sense to show the effectiveness of your quality management system? This presentation takes an ISO 13485 and 21 CFR, Part 820 approach to deciding what measurements are important, how trending makes an impact on risk-based decision-making, and why management review is just one of the ways to discuss and document your Quality Data activities.
QMS Effectiveness: Tracking and Trending Quality Data - OMTEC 2017
Capa ‘Bellwether’
1. The Significance of a CAPA
Program as a ‘Bellwether’ for
Overall Compliance Efforts
Victoria V. Lander
IDEX Corporation
21cfrpart11.com
2. What is the Cost of Quality?
"Cost of quality is the amount of money a business
loses because its product was not done right in the
first place. From fixing a warped piece on the assembly
line to having to deal with a lawsuit because of a
malfunctioning machine or a badly performed service,
businesses lose money every day due to poor quality.
For most businesses, this can run from 15 to 30
percent of their total costs."
- American Society for Quality
3. Agenda
The Quality Challenge for the GxP
Industry
What is a CAPA?
CAPA Implementation & Issues
ISO 13485 and 21 CFR Part 820
Summary
5. Quality Challenges
Increasing Role for Pharmaceuticals in Health Care
Increased Number of Products
Greater number, and wider range, of drugs being manufactured
Globalization of the Pharmaceutical Industry
Increase in foreign manufacturing sites
Advances in Pharmaceutical Science, Like Application of
Biotechnology to Drug Discovery and Manufacturing
More Complex and Diverse Manufacturing
Increasing Number of Manufacturing Supplements Submitted
for Agency Review
6. Benefits of a CAPA System
To Strive to Improve Quality
To Recognize Existing or Potential Quality Issues
To Initiate Appropriate Steps Necessary to Investigate and
Resolve these Issues
To Make Sure that the Same Issues Do Not Reoccur
Reduce Risk to Patients
Increase Quality Suppliers and Components
Products Designed and Tested to Meet Customer
Requirements
Waste Elimination
7. Satisfying Compliance With CAPA
A Proactive, Automated Approach to a Quality System
Capturing All Corrective Action Issues and Tracking CA
Processes to Completion
About 30% to 50% of All FDA 483s are Related to Problems
with CAPA Processes
Corrective Action is Core of Quality Management Disciplines
Such As...
Six Sigma DMAIC (Define, Measure, Analyze, Improve and
Control)
TOPS-8D (Team-Oriented Problem Solving, 8 Disciplines)
ISO 9000
8. Top FDA 483 Items
QSIT Inspected Firms
Records (10%)
CAPA (30%)
PAPC (20%)
Mgmt (40%)
Source: Medical Device & Diagnostic Magazine, January 2002
9. Common CAPA Violations
No Established Procedures for Implementing CAPA
No True Root-cause Analysis, Failure Investigations Inadequate
Complaint Handling Too Specific, Do Not Look at Overall System
Failure to Document CAPA Action
No Validation
Failure to Designate & Document Executive Responsibilities
Infrequent Quality Audits
Inadequate Procedures for Quality Audits
Inadequate Procedures for Design Changes
Inadequate Procedures for Documenting CAPA
Lori S. Lawless, FDA, RAPS, October 2003 in Baltimore
11. Definition
•Corrective Action – The Action to
Eliminate the Causes of a Detected
Nonconformity or Other Undesirable
Situation
•The CA Should Eliminate the
vRecurrence of an Issue
12. Definition
• Preventive Action - Action to Eliminate
the Cause of a Potential Nonconformity or
Other Undesirable Potential Situation
• PA Should Prevent Occurrence
• Examples:
• Design Reviews, Trend Activities, Audits, Process
vMonitoring, Risk Management Processes, etc.
13. CAPA is a Systematic Approach
Define the Problem
Determine Root Cause
Implement Corrective Action
Implement Preventive Action
Verify Effectiveness of Implemented CAPA
Document and Disseminate “Close-out”
A CAPA Follows an Assigned Workflow
Process…Assures All Variables Related
to Quality are Addressed
14. Key Elements of a CAPA System
Corrective Action to Eliminate the Cause of the Issues
Preventive Action to Prevent Potential Issues from
Occurring
Data Collection, Analysis and Monitoring
Prioritization of Issues Based on Risks
Active Management Participation
Comprehensive, Complete CAPA Records / Documentation
“Close the Loop” - Was the Resolution Effective?
Initiate for Deviations, Nonconformance, Out-of-Specifications,
Complaints (Reactive)
BUT… Approach Should Also be Proactive
A CAPA Solution Must be an Integrated Part of a Quality and
Compliance Solution
15. Enterprise-Wide Approach
An Internal Agreement for CAPA Definition
Must be reflected throughout entire firm
All Departments Will be Involved in CAPA
Not just Quality Assurance or Compliance
CAPA as an Integrated Part of a Sound Quality
System
It can’t function in a vacuum
Also Used to Evaluate Entire Quality System and
Other Sources of Quality Data
Effective CAPA Programs Should Fully Interact with
Change Control System
16. Define Your CAPA Process:
Key Questions
Who Will Initiate CAPAs?
How Will they be Initiated?
Will other systems drive the CAPA initiation?
How Will CAPAs be Assessed and Investigated?
How Will All CAPAs be Evaluated for their Applicability?
What Completion Requirements Set for Certain CAPA
Activities?
Length of Investigation Before Creating Correction SOP?
Interoperability of CAPA with Other Quality Processes?
e.g., PAT, QSIT, Risk Management
Did You Include Your Change Control System in Your
Planning?
How Will You Monitor CAPA System for Effectiveness?
17. Software and CAPA
Software Helps in Managing & Tracking CAPA
Process
Functionalities in a CAPA IM System Should
Include …
Web-based change management, audit trails and tracking
Visualization, reporting, and quality performance analytics
Configurable workflows
Standard template-based best practice workflows
Roles-based information view
Event management
Source: AMR Research
Integration into back-end systems
A modular structure, capable of being incrementally
deployed
18. CAPA Data Considerations
Product and Quality Data Sources
How will the Data be Captured
How will the Data be Analyzed
Including methods of analysis
When will the Data be Analyzed
What Steps are Taken After Analysis
“Review of the CAPA system document noted that all quality data
sources have not been identified, such as:
• All in-process production test data sources and the routine
analysis performed on these data sources;
• Various data sources for complaints, failure analysis and
repair data from in-house to distributors”
JUNE 11,2003
Roche Diagnostics Corporation
Indianapolis, Indiana, USA
19. Quality Data Sources
Clinical Adverse Reactions Field Service and/or
Internal, External, Supplier Warranty Reports
and Third Party Audits Corrective and Preventive
Installation Feedback Actions
Spare Part Usage Lawsuits and Other Legal
Acceptance Activity - Actions
Records Relating to Published Literature
Components Reports from Employees
In Process Failures -
Reworks and Discards
Finished Product Failures -
Reworks
Complaints - Returns and
Repairs
20. Elements of an Effective System
Use a “Closed-loop Process”
Include Written Procedures and SOPs Used to
Define the Closed-loop Process
Define Responsibility for Managing the CAPA and
Distributed it to the Organization
Establish Sequential Activities that Identify, Correct
or Eliminate Existing or Potential Problems
The tool for managing the closed-loop system
Implement an Information System for Managing the
Information Associated with CAPA
Use Effectiveness Checks to Confirm that Action
Prevented the Recurrence (or Occurrence)
23. About ISO 13485 & ISO 13488
Harmonized EU Medical Device Quality System Similar to
EN 46000 plus Additional Requirements
ISO 13485:1996: Medical Devices - Used with ISO 9001
For manufacturers performing own design activities
ISO 13488:1996: Medical Devices - Used with ISO 9002
For manufacturers without design activities
Certification of a Quality Management System to
ISO 9001/ISO 13485 (EN 46001)
Essential for Global Exportation
Third-party Verification that System Meets Requirements
US 21 CFR 820 Based on this (and ISO 9000)
24. ISO 13485 Corrective Actions
Requirements
ID Nonconformities & Determine their Cause
Including customer complaints
Evaluate Need for Action to Prevent Recurrence of
Nonconformities
Determine and Implement Action Needed, Including
Updating Documentation
Record Results of Any Investigation & Action Taken
Review Corrective Action Taken and Effectiveness
“Shall be Appropriate to the Effects of
the Nonconformities Encountered”
25. ISO 13485 Preventative Actions
Requirements
ID Potential Nonconformities and their Causes
Evaluate Need for Action to Prevent Occurrence of
Nonconformities
Determine and Implement Any Action Needed
Record Results of Any Investigation and Actions
Taken
Review Preventative Actions Taken and
Effectiveness
“Eliminate Causes of Potential Nonconformities
to Prevent their Occurrence”
26. 21 CFR Part 820: Sub-part J
ID Action Needed to Correct and/or Prevent Nonconformance
and Other Quality Problems
Employ Appropriate Statistical Methodology to Detect
Recurring Quality Problems
Investigate Causes of Nonconformities for Product, Processes
and Quality System
Ensure that Information for Quality Problems is Disseminated
to those Responsible for Assuring Product Quality
Submit Information on Quality Problems and CAPA for
Management Review
Document All Activities and Results Required Under this
Section
Verify or Validate the CAPA
27. 21 CFR Part 820: Sub-part J
Analyze the Following to ID Causes of
Nonconformance or Other Quality Problems …
Processes
Work operations
Concessions
Quality audit reports
Quality records
Service records
Complaints
Returned products
Other sources of quality data
28. FDA Warning Letter
“Failure to adequately establish and maintain
procedures for implementing corrective and
preventive action, which include requirements
for analyzing processes, work operations,
concessions, quality audit reports, quality
records, service records, complaints,
returned product, and other sources of
quality data to identify existing and potential
causes of nonconforming product or other quality
problems, as required by 21 CFR 820.100(a)
(1).” June 11, 2003
Roche Diagnostics Corporation
Indianapolis, Indiana, USA
29. The FDA and CAPA
Strength of CAPA Program is Important Indicator that
Impacts FDA Inspectors’ View of Other Compliance
Efforts
e.g. 21 CFR Part 11, Predicate Rules
When FDA Finds Strong CAPA Program at Outset of
Inspection, it’s a “Bellwether” for Your Overall Quality
Compliance Programs
Despite the FDA’s Recent Moves to Narrow Enforcement
of Part 11, Regulated Firms Should Bank on Agency
Scrutinizing CAPA More During Inspections
http://www.fda.gov/cder/gmp/index.htm
30. Summary
Address Your Culture
Conduct Independent Reviews
Simplify Documentation
Use a “Closed-Loop” System
Monitor Your Process
Change With Your Business
Participate in Industry Meetings
Talk to People/Peers
Never Stop